These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33951483)

  • 1. Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsis.
    Li X; Qi H; Jin F; Yao BF; Wu YE; Qi YJ; Kou C; Wu XR; Luo XJ; Shen YH; Zheng X; Wang YH; Xu F; Jiao WW; Li JQ; Xiao J; Dong YN; Du B; Shi HY; Xu BP; Shen AD; Zhao W
    Eur J Pharm Sci; 2021 Aug; 163():105868. PubMed ID: 33951483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants.
    Tang BH; Wu YE; Kou C; Qi YJ; Qi H; Xu HY; Leroux S; Huang X; Zhou Y; Zheng Y; Jacqz-Aigrain E; Shen AD; Zhao W
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants.
    Leroux S; Roué JM; Gouyon JB; Biran V; Zheng H; Zhao W; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6626-6634. PubMed ID: 27572399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental Population Pharmacokinetics-Pharmacodynamics of Meropenem in Chinese Neonates and Young Infants: Dosing Recommendations for Late-Onset Sepsis.
    Wu YE; Kou C; Li X; Tang BH; Yao BF; Hao GX; Zheng Y; van den Anker J; You DP; Shen AD; Zhao W
    Children (Basel); 2022 Dec; 9(12):. PubMed ID: 36553441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetics and Dosing Optimization of Ceftazidime in Infants.
    Shi ZR; Chen XK; Tian LY; Wang YK; Zhang GY; Dong L; Jirasomprasert T; Jacqz-Aigrain E; Zhao W
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Dosing of Ceftriaxone in Infants Based on a Developmental Population Pharmacokinetic-Pharmacodynamic Analysis.
    Wang YK; Wu YE; Li X; Tian LY; Khan MW; Tang BH; Shi HY; Zheng Y; Hao GX; van den Anker J; You DP; Zhao W
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.
    Zhao W; Hill H; Le Guellec C; Neal T; Mahoney S; Paulus S; Castellan C; Kassai B; van den Anker JN; Kearns GL; Turner MA; Jacqz-Aigrain E;
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6572-80. PubMed ID: 25155587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Chinese Infants.
    Wu YE; Wang YK; Tang BH; Dong L; Li X; Zhang W; Li DF; Tian LY; van den Anker J; You DP; Zhao W
    J Clin Pharmacol; 2021 Apr; 61(4):538-546. PubMed ID: 32996155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants.
    Zhou J; Jiang L; Zhang ZL; Wang ZR; Zhang YX; Lin X; Tang BH; Yao BF; Guo ZX; Yang JJ; Van Den Anker J; Wu YE; Zhao W
    J Antimicrob Chemother; 2022 Jul; 77(8):2238-2244. PubMed ID: 35662337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftazidime dosage recommendations in burn patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations.
    Conil JM; Georges B; Ravat F; Ruiz S; Seguin T; Metsu D; Fourcade O; Saivin S
    Clin Ther; 2013 Oct; 35(10):1603-12. PubMed ID: 24094465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants.
    Zhao Y; Yao BF; Kou C; Xu HY; Tang BH; Wu YE; Hao GX; Zhang XP; Zhao W
    Front Pharmacol; 2020; 11():14. PubMed ID: 32116695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Pharmacokinetics and Dosing Considerations for Gentamicin in Newborns with Suspected or Proven Sepsis Caused by Gram-Negative Bacteria.
    Bijleveld YA; van den Heuvel ME; Hodiamont CJ; Mathôt RA; de Haan TR
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?
    Kontou A; Sarafidis K; Begou O; Gika HG; Tsiligiannis A; Ogungbenro K; Dokoumetzidis A; Agakidou E; Roilides E
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infants.
    Qi H; Kou C; Qi YJ; Tang BH; Wu YE; Jin F; Luo XJ; Shen YH; Guo YJ; Qi X; Wang YC; Dong Q; Chen XK; Shi HY; Zheng Y; Zhao W; Shen AD
    Int J Antimicrob Agents; 2019 Mar; 53(3):347-351. PubMed ID: 30472290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia.
    Cies JJ; Fugarolas KN; Moore WS; Mason RW; Menkiti OR
    Pharmacotherapy; 2017 Apr; 37(4):456-463. PubMed ID: 28226400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study design.
    Tremoulet A; Le J; Poindexter B; Sullivan JE; Laughon M; Delmore P; Salgado A; Ian-U Chong S; Melloni C; Gao J; Benjamin DK; Capparelli EV; Cohen-Wolkowiez M;
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3013-20. PubMed ID: 24614374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and external evaluation of a population pharmacokinetic model for continuous and intermittent administration of vancomycin in neonates and infants using prospectively collected data.
    Germovsek E; Osborne L; Gunaratnam F; Lounis SA; Busquets FB; Standing JF; Sinha AK
    J Antimicrob Chemother; 2019 Apr; 74(4):1003-1011. PubMed ID: 30668696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Pharmacokinetics and Dosing Simulations of Ceftazidime in Chinese Neonates.
    Wang H; Li X; Sun S; Mao G; Xiao P; Fu C; Liang Z; Zheng M; Huang Y; Tang H; Ou R; Yang N; Ling X; Zhao Z
    J Pharm Sci; 2018 May; 107(5):1416-1422. PubMed ID: 29274818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates.
    Kato H; Hagihara M; Nishiyama N; Koizumi Y; Mikamo H; Matsuura K; Yamagishi Y
    J Infect Chemother; 2017 Mar; 23(3):154-160. PubMed ID: 28017667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of Penicillin G in Preterm and Term Neonates.
    Padari H; Metsvaht T; Germovsek E; Barker CI; Kipper K; Herodes K; Standing JF; Oselin K; Tasa T; Soeorg H; Lutsar I
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.